HAVCR2 and acute myeloid leukemia: Since human acute myeloid leukemia (AML) cells express high levels of TIM-3 receptor [99], Yasinska et al. designed a nanocomplex formed by AuNPs carrying on their surface Abs against TIM-3 in order to target AML cells [100].